Correlation Between Avenue Therapeutics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Avenue Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avenue Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avenue Therapeutics and Transcode Therapeutics, you can compare the effects of market volatilities on Avenue Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avenue Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avenue Therapeutics and Transcode Therapeutics.
Diversification Opportunities for Avenue Therapeutics and Transcode Therapeutics
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Avenue and Transcode is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Avenue Therapeutics and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Avenue Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avenue Therapeutics are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Avenue Therapeutics i.e., Avenue Therapeutics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Avenue Therapeutics and Transcode Therapeutics
Given the investment horizon of 90 days Avenue Therapeutics is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Avenue Therapeutics is 2.85 times less risky than Transcode Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 353.00 in Transcode Therapeutics on November 3, 2024 and sell it today you would earn a total of 403.00 from holding Transcode Therapeutics or generate 114.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Avenue Therapeutics vs. Transcode Therapeutics
Performance |
| Timeline |
| Avenue Therapeutics |
| Transcode Therapeutics |
Avenue Therapeutics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avenue Therapeutics and Transcode Therapeutics
The main advantage of trading using opposite Avenue Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avenue Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Virax Biolabs Group | Avenue Therapeutics vs. Palisade Bio |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets |